Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00001
http://purl.obolibrary.org/obo/dinto_DB00001
|
|---|---|
| Preferred Name | lepirudin |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | lepirudin
|
|---|---|
| label | lepirudin
|
| DBSynonym | hirudin variant-1
|
| ATCCode | B01AE02
|
| Definition | Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| inhibits | |
| type | |
| AHFScode | 20:12.04.12
|
| xref |
Drugs.com:http://www.drugs.com/cdi/lepirudin.html
Wikipedia:http://en.wikipedia.org/wiki/Lepirudin
RxList:http://www.rxlist.com/cgi/generic/lepirudin.htm
National Drug Code Directory:50419-150-57
UniProtKB:P01050
Drugs Product Database (DPD):2240996
PharmGKB:PA450195
See more
See less
|
| CASRN | 120993-53-5
|
| prefixIRI | obo2:dinto_DB00001
|
| may interact with | |
| DBBrand | refludan
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |